tetano
Editor, Senior Moderator
mBio
. 2021 Mar 2;12(2):e00230-21.
doi: 10.1128/mBio.00230-21.
Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
Young-Il Kim[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Dokyun Kim[SUP] #[/SUP][SUP] 4 5 [/SUP], Kwang-Min Yu[SUP] 1 2 3 [/SUP], Hogyu David Seo[SUP] 4 5 [/SUP], Shin-Ae Lee[SUP] 4 5 [/SUP], Mark Anthony B Casel[SUP] 1 2 3 [/SUP], Seung-Gyu Jang[SUP] 1 2 3 [/SUP], Stephanie Kim[SUP] 4 5 [/SUP], WooRam Jung[SUP] 4 5 [/SUP], Chih-Jen Lai[SUP] 4 5 [/SUP], Young Ki Choi[SUP] 6 2 3 [/SUP], Jae U Jung[SUP] 7 5 [/SUP]
Affiliations
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a causative agent of the CoV disease 2019 (COVID-19) pandemic, enters host cells via the interaction of its receptor-binding domain (RBD) of the spike protein with host angiotensin-converting enzyme 2 (ACE2). Therefore, the RBD is a promising vaccine target to induce protective immunity against SARS-CoV-2 infection. In this study, we report the development of an RBD protein-based vaccine candidate against SARS-CoV-2 using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. RBD-ferritin protein purified from mammalian cells efficiently assembled into 24-mer nanoparticles. Sixteen- to 20-month-old ferrets were vaccinated with RBD-ferritin nanoparticles (RBD nanoparticles) by intramuscular or intranasal inoculation. All vaccinated ferrets with RBD nanoparticles produced potent neutralizing antibodies against SARS-CoV-2. Strikingly, vaccinated ferrets demonstrated efficient protection from SARS-CoV-2 challenge, showing no fever, body weight loss, or clinical symptoms. Furthermore, vaccinated ferrets showed rapid clearance of infectious virus in nasal washes and lungs as well as of viral RNA in respiratory organs. This study demonstrates that spike RBD-nanoparticles are an effective protein vaccine candidate against SARS-CoV-2.
Keywords: coronavirus; ferret; ferritin; immunization; nanoparticle; receptor-binding domain; vaccines.
. 2021 Mar 2;12(2):e00230-21.
doi: 10.1128/mBio.00230-21.
Development of Spike Receptor-Binding Domain Nanoparticles as a Vaccine Candidate against SARS-CoV-2 Infection in Ferrets
Young-Il Kim[SUP] #[/SUP][SUP] 1 2 3 [/SUP], Dokyun Kim[SUP] #[/SUP][SUP] 4 5 [/SUP], Kwang-Min Yu[SUP] 1 2 3 [/SUP], Hogyu David Seo[SUP] 4 5 [/SUP], Shin-Ae Lee[SUP] 4 5 [/SUP], Mark Anthony B Casel[SUP] 1 2 3 [/SUP], Seung-Gyu Jang[SUP] 1 2 3 [/SUP], Stephanie Kim[SUP] 4 5 [/SUP], WooRam Jung[SUP] 4 5 [/SUP], Chih-Jen Lai[SUP] 4 5 [/SUP], Young Ki Choi[SUP] 6 2 3 [/SUP], Jae U Jung[SUP] 7 5 [/SUP]
Affiliations
- PMID: 33653891
- DOI: 10.1128/mBio.00230-21
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a causative agent of the CoV disease 2019 (COVID-19) pandemic, enters host cells via the interaction of its receptor-binding domain (RBD) of the spike protein with host angiotensin-converting enzyme 2 (ACE2). Therefore, the RBD is a promising vaccine target to induce protective immunity against SARS-CoV-2 infection. In this study, we report the development of an RBD protein-based vaccine candidate against SARS-CoV-2 using self-assembling Helicobacter pylori-bullfrog ferritin nanoparticles as an antigen delivery system. RBD-ferritin protein purified from mammalian cells efficiently assembled into 24-mer nanoparticles. Sixteen- to 20-month-old ferrets were vaccinated with RBD-ferritin nanoparticles (RBD nanoparticles) by intramuscular or intranasal inoculation. All vaccinated ferrets with RBD nanoparticles produced potent neutralizing antibodies against SARS-CoV-2. Strikingly, vaccinated ferrets demonstrated efficient protection from SARS-CoV-2 challenge, showing no fever, body weight loss, or clinical symptoms. Furthermore, vaccinated ferrets showed rapid clearance of infectious virus in nasal washes and lungs as well as of viral RNA in respiratory organs. This study demonstrates that spike RBD-nanoparticles are an effective protein vaccine candidate against SARS-CoV-2.
Keywords: coronavirus; ferret; ferritin; immunization; nanoparticle; receptor-binding domain; vaccines.